华康生物医学10月9日下午短暂停牌 待公布内幕消息

Core Viewpoint - Huakang Biomedical (08622) has announced that its shares will be suspended from trading on the Hong Kong GEM starting from October 9, 2025, at 1:00 PM, pending the issuance of an announcement containing inside information in accordance with the Hong Kong Code on Takeovers and Mergers [1] Group 1 - The suspension of trading is a regulatory measure in response to the need for disclosure of inside information [1] - The announcement indicates potential significant developments regarding the company that may impact its stock performance [1]